Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
IO Biotech, Inc. (IOBT) had Return on Tangible Equity of -84.86% for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-22.42M |
|
-- |
|
-- |
|
$22.58M |
|
$-22.58M |
|
$0.31M |
|
$-22.27M |
|
$-22.27M |
|
$-22.42M |
|
$-22.42M |
|
$-22.42M |
|
$-22.42M |
|
$-22.58M |
|
$-22.52M |
|
65.88M |
|
65.88M |
|
$-0.34 |
|
$-0.34 |
|
| Balance Sheet Financials | |
$42.34M |
|
$0.62M |
|
$3.39M |
|
$45.74M |
|
$18.29M |
|
-- |
|
$1.03M |
|
$19.31M |
|
$26.42M |
|
$26.42M |
|
$26.42M |
|
65.88M |
|
| Cash Flow Statement Financials | |
$-23.07M |
|
$-0.03M |
|
-- |
|
$60.30M |
|
$37.35M |
|
$-22.95M |
|
$1.57M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.32 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-23.10M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-84.86% |
|
|
Return on Tangible Equity |
-84.86% |
-49.02% |
|
-84.86% |
|
$0.40 |
|
$-0.35 |
|
$-0.35 |
|